EVH
Evolent Health, Inc.
Set alert
4.30 USD +0.05 +1.18%
4.09 Day range 4.31
2.17 52-week range 6.72
- YTD
- +7.50%
- 1 year
- -34.85%
- Open
- 4.26
- Prev close
- 4.25
- Mkt cap
- 486.16M
- Vol
- 1.15M
- Avg vol
- 2.54M
- EPS
- -4.49
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.09
- High
- 4.31
- Forward P/E
- 6.01
- Beta
- 0.73
- Short ratio
- 6.55
- Inst. own
- 108.70%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 6, 2025
- 50-d avg
- 9.86
- 200-d avg
- 9.96
- 1y target
- 15.46
Key statistics
- Market cap
- 997.35M
- Enterprise value
- 1.98B
- Trailing P/E
- 0.00
- Forward P/E
- 6.01
- PEG ratio
- 0.00
- Price / sales
- 0.45
- Price / book
- 1.11
- EPS (TTM)
- -1.60
- Beta
- 0.73
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -5.94%
- Revenue (TTM)
- 2.20B
- Revenue growth
- -31.30%
- Free cash flow
- -77.39M
- Total cash
- 151.00M
- Total debt
- 853.19M
- Return on equity
- -11.04%
- Shares outstanding
- 115.97M
- Short % of float
- 19.74%
- 50-day average
- 9.86
- 200-day average
- 9.96
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 15.46 +259.6% upside
Now 4.30
- Target (low)
- 9.00
- Target (mean)
- 15.46
- Target (high)
- 20.00
Ratings (0m) 14 13 buy · 1 hold · 0 sell
- Strong buy4
- Buy9
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 6, 2025
Expected Nov 6, 2025. Consensus EPS estimate 0.10522.
Financials — quick view
EVH Revenue — quarterly 652.52M
EVH Net income — quarterly -28.36M
EVH EPS — quarterly -0.25
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2025 | Sep 1, 2025 | 0.10 | — | — | — |
| Aug 7, 2025 | Jun 1, 2025 | 0.09 | — | -0.19 | -211.11% |
| May 8, 2025 | Mar 1, 2025 | 0.09 | 0.06 | -0.03 | -33.33% |
| Nov 7, 2024 | Sep 1, 2024 | 0.30 | 0.04 | -0.26 | -86.67% |
| Aug 8, 2024 | Jun 1, 2024 | 0.21 | 0.30 | +0.09 | +42.86% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 9, 2025 | Canaccord Genuity | main | Buy | Buy |
| Sep 9, 2025 | BTIG | reit | Buy | Buy |
| Aug 28, 2025 | Piper Sandler | main | Overweight | Overweight |
| Jul 17, 2025 | Truist Securities | main | Buy | Buy |
| Jun 20, 2025 | JMP Securities | reit | Market Outperform | Market Outperform |
| May 13, 2025 | Needham | reit | Buy | Buy |
About Evolent Health, Inc.
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management; and Machinify Auth, a software platform that leverages advances in artificial intelligence. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- evolent.com
News
- Analyzing CareCloud (NASDAQ:CCLD) & Evolent Health (NYSE:EVH)
- Evolent To Release Third Quarter 2026 Financial Results on Thursday, November 5, 2026
- Evolent Health, Inc (NYSE:EVH) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
- TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation
- JP Morgan Maintains Overweight on Evolent Health, Raises Price Target to $6
- TD Cowen Maintains Buy on Evolent Health, Raises Price Target to $6
- Evolent Health Q2 Earnings Review: Debt Is Distressing, But Business Is Booming
- Dimensional Fund Advisors LP Has $4.08 Million Stock Position in Evolent Health, Inc $EVH
- Truist Securities Maintains Hold on Evolent Health, Lowers Price Target to $6
- Citigroup Upgrades Evolent Health to Buy, Lowers Price Target to $6
Your note
Sign in to keep a note on EVH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARBAROSH CRAIG A | Director | Stock Award(Grant) | Jun 4, 2025 | 53,935 |
| BLACKLEY SETH | Chief Executive Officer | Stock Award(Grant) | Jun 30, 2025 | 829,367 |
| GRUA PETER J | Director | Stock Award(Grant) | Jun 4, 2025 | 82,647 |
| GUERTIN SHAWN M | Director | Stock Award(Grant) | Jun 4, 2025 | 21,979 |
| JELINEK RICHARD M | Director | Stock Award(Grant) | Jun 4, 2025 | 66,437 |
| JOHNSON JOHN PAUL | Chief Financial Officer | Stock Award(Grant) | Jun 30, 2025 | 309,245 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 9.29% | 10,921,531 | 93.93M | Jun 29, 2025 |
| Cadian Capital Management, LP | 8.87% | 10,424,701 | 89.65M | Jun 29, 2025 |
| Blackrock Inc. | 7.98% | 9,376,620 | 80.64M | Jun 29, 2025 |
| Morgan Stanley | 6.85% | 8,052,587 | 69.25M | Jun 29, 2025 |
| Durable Capital Partners Lp | 5.47% | 6,423,293 | 55.24M | Jun 29, 2025 |
| FMR, LLC | 5.46% | 6,420,384 | 55.22M | Jun 29, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 5.77% | 6,778,267 | 58.29M | Apr 29, 2025 |
| Fidelity Securities Fund-Fidelity Small Cap Value Fund | 3.31% | 3,894,086 | 33.49M | Jun 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.04% | 3,567,642 | 30.68M | Jun 29, 2025 |
| iShares Trust-iShares Russell 2000 ETF | 2.47% | 2,906,857 | 25.00M | Jun 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.32% | 2,725,731 | 23.44M | Jun 29, 2025 |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 1.76% | 2,070,815 | 17.81M | Jun 29, 2025 |